The global pharmacovigilance software market size is projected to grow by USD 78.0 million from 2022 to 2028, registering a CAGR of 6.2 percent, according to a new report by Gen Consulting Company.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmacovigilance software market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmacovigilance software industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the functionality, delivery mode, end user, and region. The global market for pharmacovigilance software can be segmented by functionality: adverse event reporting software, drug safety audits software, issue tracking software, fully integrated software. In 2021, the adverse event reporting software segment made up the largest share of revenue generated by the pharmacovigilance software market. Pharmacovigilance software market is further segmented by delivery mode: on-premise delivery, cloud-based delivery. The cloud-based delivery segment was the largest contributor to the global pharmacovigilance software market in 2021. Based on end user, the pharmacovigilance software market is segmented into: pharmaceutical company, contract research organizations, business process outsourcing firm, others. The contract research organizations segment is estimated to account for the largest share of the global pharmacovigilance software market. On the basis of region, the pharmacovigilance software market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global pharmacovigilance software market in 2021 and is anticipated to hold its share during the forecast period.

Market Segmentation
By functionality: adverse event reporting software, drug safety audits software, issue tracking software, fully integrated software
By delivery mode: on-premise delivery, cloud-based delivery
By end user: pharmaceutical company, contract research organizations, business process outsourcing firm, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Pharmacovigilance Software Market, including Accenture Inc., ArisGlobal LLC, IQVIA Inc., Oracle Corporation, Sparta Systems Inc., United BioSource LLC, Veeva Systems Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global pharmacovigilance software market.
– To classify and forecast the global pharmacovigilance software market based on functionality, delivery mode, end user, region.
– To identify drivers and challenges for the global pharmacovigilance software market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmacovigilance software market.
– To identify and analyze the profile of leading players operating in the global pharmacovigilance software market.

Why Choose This Report
– Gain a reliable outlook of the global pharmacovigilance software market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.